A practical guide for induction of type-2 diabetes in rat: Incorporating a high-fat diet and streptozotocin

Biomedicine and Pharmacotherapy

Volumn 95, Issue , 2017, Pages 605-613

  Gheibi, Sevda ^a,b   Kashfi, Khosrow ^c   Ghasemi, Asghar ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c CITY UNIVERSITY OF NEW YORK MEDICAL SCHOOL   (United States)

Author keywords

Animal model; High fat diet; Metabolism; Streptozotocin; Type 2 diabetes

Indexed keywords

INSULIN; STREPTOZOCIN;

BODY WEIGHT; CLINICAL FEATURE; DISEASE MODEL; FOOD INTAKE; LIPID DIET; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; RAT; REVIEW; ANIMAL; BIOLOGICAL MODEL; EXPERIMENTAL DIABETES MELLITUS; GENETICS; METABOLISM; PATHOLOGY;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; DIET, HIGH-FAT; INSULIN; MODELS, BIOLOGICAL; RATS; STREPTOZOCIN;

EID: 85028725029     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2017.08.098     Document Type: Review

References (120)

1. International Diabetes Federation, IDF Diabetes Atlas. 7th ed., 2015, International Diabetes Federation, Brussels, Belgium.
2. Podell, B.K., Ackart, D.F., Richardson, M.A., DiLisio, J.E., Pulford, B., Basaraba, R.J., A model of type 2 diabetes in the guinea pig using sequential diet-induced glucose intolerance and streptozotocin treatment. Dis. Model Mech. 10:2 (2017), 151–162, 10.1242/dmm.025593.
3. Ghasemi, A., Jeddi, S., Anti-obesity and anti-diabetic effects of nitrate and nitrite. Nitric Oxide, 2017, 10.1016/j.niox.2017.08.003.
4. Gheibi, S., Bakhtiarzadeh, F., Jeddi, S., Farrokhfall, K., Zardooz, H., Ghasemi, A., Nitrite increases glucose-stimulated insulin secretion and islet insulin content in obese type 2 diabetic male rats. Nitric Oxide 64 (2017), 39–51, 10.1016/j.niox.2017.01.003.
5. Srinivasan, K., Ramarao, P., Animal models in type 2 diabetes research: an overview. Indian J. Med. Res. 125:3 (2007), 451–472.
6. Szkudelski, T., The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. Physiol. Res. 50:6 (2001), 537–546.
7. Ghasemi, A., Khalifi, S., Jedi, S., Streptozotocin-nicotinamide-induced rat model of type 2 diabetes. Acta Physiol. Hung. 101:4 (2014), 408–420, 10.1556/APhysiol.101.2014.4.2 (review).
8. Kashfi, K., Cagen, L., Cook, G.A., Diabetes and proteolysis: effects on carnitine palmitoyltransferase-I and malonyl-CoA binding. Lipids 30:5 (1995), 383–388.
9. Reed, M.J., Meszaros, K., Entes, L.J., Claypool, M.D., Pinkett, J.G., Gadbois, T.M., Reaven, G.M., A new rat model of type 2 diabetes: the fat-fed, streptozotocin-treated rat. Metabolism. 49 (2000), 1390–1394.
10. Srinivasan, K., Viswanad, B., Asrat, L., Kaul, C.L., Ramarao, P., Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening. Pharmacol. Res. 52 (2005), 313–320, 10.1016/j.phrs.2005.05.004.
11. Zhang, M., Lv, X., Li, J., Xu, Z., Chen, L., The characterization of high-fat diet and multiple low-dose streptozotocin induced type 2 diabetes rat model. Exp. Diabet. Res., 2008, 2008, 704045, 10.1155/2008/704045.
12. Kongkachuichai, R., Prangthip, P., Surasiang, R., Posuwan, J., Charoensiri, R., Kettawan, A., Vanavichit, A., Effect of Riceberry oil (deep purple oil; Oryza sativa Indica) supplementation on hyperglycemia and change in lipid profile in Streptozotocin (STZ)-induced diabetic rats fed a high fat diet. Int. Food Res. J. 20:2 (2013), 873–882.
13. Sankar, P., Subhashree, S., Sudharani, S., Effect of Trigonella foenum-graecum seed powder on the antioxidant levels of high fat diet and low dose streptozotocin induced type II diabetic rats. Eur. Rev. Med. Pharmacol. Sci. 16:3 (2012), 10–17.
14. Doan, V.B., Nguyen, T.K.D., Le, T.B.T., Nguyen, B.N., Phan, V.C., Macro- and microvascular complications of diabetes induced by high-fat diet and low-dose streptozotocin injection in rats model. Int. J. Diabet. Res. 2:3 (2013), 50–55, 10.5923/j.diabetes.20130203.03.
15. Zhang, Y., Wang, P., Xu, Y., Meng, X., Metabolomic analysis of biochemical changes in the plasma of high-fat diet and streptozotocin-induced diabetic rats after treatment with isoflavones extract of Radix Puerariae. Evid. Based Complement. Alternat. Med., 2016, 2016, 4701890, 10.1155/2016/4701890.
16. Sampath, C., Rashid, M.R., Sang, S., Ahmedna, M., Green tea epigallocatechin 3-gallate alleviates hyperglycemia and reduces advanced glycation end products via nrf2 pathway in mice with high fat diet-induced obesity. Biomed. Pharmacother. 87 (2017), 73–81, 10.1016/j.biopha.2016.12.082.
17. Asrafuzzaman, M., Cao, Y., Afroz, R., Kamato, D., Gray, S., Little, P.J., Animal models for assessing the impact of natural products on the aetiology and metabolic pathophysiology of Type 2 diabetes. Biomed. Pharmacother. 89 (2017), 1242–1251, 10.1016/j.biopha.2017.03.010.
18. Flanagan, A.M., Brown, J.L., Santiago, C.A., Aad, P.Y., Spicer, L.J., Spicer, M.T., High-fat diets promote insulin resistance through cytokine gene expression in growing female rats. J. Nutr. Biochem. 19:8 (2008), 505–513, 10.1016/j.jnutbio.2007.06.005.
19. Gheibi, S., Bakhtiarzadeh, F., Ghasemi, A., A review of high fat diet-streptozotocin model for induction of type 2 diabetes in rat. Iran. J. Endocrinol. Metab. 18:2 (2016), 135–148.
20. King, A.J., The use of animal models in diabetes research. Br. J. Pharmacol. 166:3 (2012), 877–894, 10.1111/j.1476-5381.2012.01911.x.
21. Reeves, P.G., Components of the AIN-93 diets as improvements in the AIN-76A diet. J. Nutr., 2014.
22. Gajda, A.M., Pellizzon, M.A., Ricci, M.R., Ulman, E.A., Diet-induced metabolic syndrome in rodent models. Anim. Lab News 74 (2007), 775–793.
23. Tierney, A.C., Roche, H.M., The potential role of olive oil-derived MUFA in insulin sensitivity. Mol. Nutr. Food Res. 51:10 (2007), 1235–1248, 10.1002/mnfr.200700143.
24. Hou, L., Lian, K., Yao, M., Shi, Y., Lu, X., Fang, L., He, T., Jiang, L., Reduction of n-3 PUFAs, specifically DHA and EPA, and enhancement of peroxisomal beta-oxidation in type 2 diabetic rat heart. Cardiovasc. Diabetol., 11, 2012, 126, 10.1186/1475-2840-11-126.
25. Gandhi, G.R., Stalin, A., Balakrishna, K., Ignacimuthu, S., Paulraj, M.G., Vishal, R., Insulin sensitization via partial agonism of PPARgamma and glucose uptake through translocation and activation of GLUT4 in PI3K/p-Akt signaling pathway by embelin in type 2 diabetic rats. Biochim. Biophys. Acta 1830:1 (2013), 2243–2255, 10.1016/j.bbagen.2012.10.016.
26. Mansor, L.S., Gonzalez, E.R., Cole, M.A., Tyler, D.J., Beeson, J.H., Clarke, K., Carr, C.A., Heather, L.C., Cardiac metabolism in a new rat model of type 2 diabetes using high-fat diet with low dose streptozotocin. Cardiovasc. Diabetol., 12, 2013, 136, 10.1186/1475-2840-12-136.
27. Atanasovska, E., Tasic, V., Slaninka-Miceska, M., Alabakovska, S., Zafirov, D., Kostova, E., Pavlovska, K., Filipce, V., Labacevski, N., Six week follow-up of metabolic effects induced by a high-fat diet and streptozotocin in a rodent model of type 2 diabetes mellitus. Contrib. Sec. Med. Sci 1 (2014), 170–179.
28. Buettner, R., Parhofer, K.G., Woenckhaus, M., Wrede, C.E., Kunz-Schughart, L.A., Scholmerich, J., Bollheimer, L.C., Defining high-fat-diet rat models: metabolic and molecular effects of different fat types. J. Mol. Endocrinol. 36:3 (2006), 485–501, 10.1677/jme.1.01909.
29. Storlien, L.H., Baur, L.A., Kriketos, A.D., Pan, D.A., Cooney, G.J., Jenkins, A.B., Calvert, G.D., Campbell, L.V., Dietary fats and insulin action. Diabetologia 39:6 (1996), 621–631.
30. Rivellese, A.A., Lilli, S., Quality of dietary fatty acids, insulin sensitivity and type 2 diabetes. Biomed. Pharmacother. 57:2 (2003), 84–87.
31. Ikemoto, S., Takahashi, M., Tsunoda, N., Maruyama, K., Itakura, H., Ezaki, O., High-fat diet-induced hyperglycemia and obesity in mice: differential effects of dietary oils. Metabolism. 45:12 (1996), 1539–1546.
32. Singh, S.R., Sharma, R.K., Malhotra, S., Pothuraju, R., Shandilya, U.K., Assessment of gut associated changes and adipose tissue inflammation in high fat diet fed Streptozotocin-induced diabetic rats. J. Innov. Biol. 1:2 (2014), 68–77.
33. Sahin, K., Onderci, M., Tuzcu, M., Ustundag, B., Cikim, G., Ozercan, I.H., Sriramoju, V., Juturu, V., Komorowski, J.R., Effect of chromium on carbohydrate and lipid metabolism in a rat model of type 2 diabetes mellitus: the fat-fed, streptozotocin-treated rat. Metabolism. 56:9 (2007), 1233–1240, 10.1016/j.metabol.2007.04.021.
34. Haggag, Mel.-S., Elsanhoty, R.M., Ramadan, M.F., Impact of dietary oils and fats on lipid peroxidation in liver and blood of albino rats. Asian Pac. J. Trop. Biomed. 4:1 (2014), 52–58, 10.1016/s2221-1691(14)60208-2.
35. Lau, B.Y., Fajardo, V.A., McMeekin, L., Sacco, S.M., Ward, W.E., Roy, B.D., Peters, S.J., Leblanc, P.J., Influence of high-fat diet from differential dietary sources on bone mineral density, bone strength, and bone fatty acid composition in rats. Appl. Physiol. Nutr. Metab. 35:5 (2010), 598–606, 10.1139/H10-052.
36. Karbaschi, R., Sadeghimahalli, F., Zardooz, H., Maternal high-fat diet inversely affects insulin sensitivity in dams and young adult male rat offspring. J. Zhejiang Univ. Sci. B 17:9 (2016), 728–732, 10.1631/jzus.B1600131.
37. Buettner, R., Scholmerich, J., Bollheimer, L.C., High-fat diets: modeling the metabolic disorders of human obesity in rodents. Obesity (Silver Spring) 15:4 (2007), 798–808, 10.1038/oby.2007.608.
38. Skovsø, S., Modeling type 2 diabetes in rats using high fat diet and streptozotocin. J. Diabetes Invest. 5 (2014), 349–358, 10.1111/jdi.12235.
39. Medinsky, M.A., Popp, J.A., Hamm, T.E., Dent, J.G., Development of hepatic lesions in male Fischer-344 rats fed AIN-76A purified diet. Toxicol. Appl. Pharmacol. 62 (1982), 111–120.
40. Bergstra, A.E., Lemmens, A.G., Beynen, A.C., Dietary fructose vs glucose stimulates nephrocalcinogenesis in female rats. J. Nutr. 123 (1993), 1320–1327.
41. Szkudelski, T., Streptozotocin-nicotinamide-induced diabetes in the rat. Characteristics of the experimental model. Exp. Biol. Med. (Maywood) 237:5 (2012), 481–490, 10.1258/ebm.2012.011372.
42. Deeds, M.C., Anderson, J.M., Armstrong, A.S., Gastineau, D.A., Hiddinga, H.J., Jahangir, A., Eberhardt, N.L., Kudva, Y.C., Single dose streptozotocin-induced diabetes: considerations for study design in islet transplantation models. Lab. Anim. 45:3 (2011), 131–140, 10.1258/la.2010.010090.
43. Ozturk, Y., Altan, V.M., Yildizoglu-Ari, N., Effects of experimental diabetes and insulin on smooth muscle functions. Pharmacol. Rev. 48:1 (1996), 69–112.
44. Kolb, H., Mouse models of insulin dependent diabetes: Low-dose streptozocin-induced diabetes and nonobese diabetic (NOD) mice. Diabetes Metab. Rev. 3:3 (1987), 751–778, 10.1002/dmr.5610030308.
45. Furman, B.L., Streptozotocin-induced diabetic models in mice and rats. Curr. Protoc. Pharmacol. 70 (2015), 1–20, 10.1002/0471141755.ph0547s70 5.47.
46. McNeill, J.H., Experimental Models of Diabetes. 1999, CRC Press.
47. Candela, S., Hernandez, R.E., Gagliardino, J.J., Circadian variation of the streptozotocin-diabetogenic effect in mice. Experientia 35:9 (1979), 1256–1257.
48. Tay, Y.C., Wang, Y., Kairaitis, L., Rangan, G.K., Zhang, C., Harris, D.C., Can murine diabetic nephropathy be separated from superimposed acute renal failure?. Kidney Int. 68:1 (2005), 391–398, 10.1111/j.1523-1755.2005.00405.x.
49. Program, N.T., Report on Carcinogens., 12th ed., 2011, DIANE Publishing Company.
50. Ghelani, H., Razmovski-Naumovski, V., Nammi, S., Chronic treatment of (R)-α-lipoic acid reduces blood glucose and lipid levels in high-fat diet and low-dose streptozotocin-induced metabolic syndrome and type 2 diabetes in Sprague-Dawley rats. Pharmacol. Res. Perspect., 5(3), 2017, e00306, 10.1002/prp2.306.
51. Nath, S., Ghosh, S.K., Choudhury, Y., A murine model of type 2 diabetes mellitus developed using a combination of high fat diet and multiple low doses of streptozotocin treatment mimics the metabolic characteristics of type 2 diabetes mellitus in humans. J. Pharmacol. Toxicol. Methods 84 (2017), 20–30, 10.1016/j.vascn.2016.10.007.
52. Li, Y., Zhang, T., Zhang, X., Zou, W., Gong, X., Fu, J., Cinepazide maleate improves cognitive function and protects hippocampal neurons in diabetic rats with chronic cerebral hypoperfusion. Biol. Pharm. Bull. 40:3 (2017), 249–255, 10.1248/bpb.b16-00567.
53. Chaudhari, H.S., Bhandari, U., Khanna, G., Embelia ribes extract reduces high fat diet and low dose streptozotocin-induced diabetic nephrotoxicity in rats. EXCLI J. 12 (2013), 858–871.
54. Parveen, K., Khan, R., Siddiqui, W.A., Antidiabetic effects afforded by Terminalia arjuna in high fat-fed and streptozotocin-induced type 2 diabetic rats. Int. J. Diabetes Metab. 19 (2011), 23–33.
55. Mahmoud, A.M., Ashour, M.B., Abdel-Moneim, A., Ahmed, O.M., Hesperidin and naringin attenuate hyperglycemia-mediated oxidative stress and proinflammatory cytokine production in high fat fed/streptozotocin-induced type 2 diabetic rats. J. Diabetes Complicat. 26:6 (2012), 483–490, 10.1016/j.jdiacomp.2012.06.001.
56. Abo-elmatty, D.M., Essawy, S.S., Badr, J.M., Sterner, O., Antioxidant and anti-inflammatory effects of Urtica pilulifera extracts in type 2 diabetic rats. J. Ethnopharmacol. 145:1 (2013), 269–277, 10.1016/j.jep.2012.11.002.
57. Parveen, K., Khan, M.R., Mujeeb, M., Siddiqui, W.A., Protective effects of Pycnogenol on hyperglycemia-induced oxidative damage in the liver of type 2 diabetic rats. Chem. Biol. Interact. 186:2 (2010), 219–227, 10.1016/j.cbi.2010.04.023.
58. Saliu, J.A., Oboh, G., Omojokun, O.S., Rocha, J.B., Schetinger, M.R., Guterries, J., Stefanello, N., Carvalho, F., Schmatz, R., Morsch, V.M., Boligon, A., Effect of dietary supplementation of Padauk (Pterocarpus soyauxii) leaf on high fat diet/streptozotocin induced diabetes in rats’ brain and platelets. Biomed. Pharmacother. 84 (2016), 1194–1201, 10.1016/j.biopha.2016.10.043.
59. Gaballah, H.H., Zakaria, S.S., Mwafy, S.E., Tahoon, N.M., Ebeid, A.M., Mechanistic insights into the effects of quercetin and/or GLP-1 analogue liraglutide on high-fat diet/streptozotocin-induced type 2 diabetes in rats. Biomed. Pharmacother. 92 (2017), 331–339, 10.1016/j.biopha.2017.05.086.
60. Kulkarni, Y.A., Garud, M.S., Bauhinia variegata Bauhinia variegata (Caesalpiniaceae) leaf extract: an effective treatment option in type I and type II diabetes. Biomed. Pharmacother. 83 (2016), 122–129, 10.1016/j.biopha.2016.06.025.
61. El-Gharbawy, R.M., Emara, A.M., Abu-Risha, S.E., Zinc oxide nanoparticles and a standard antidiabetic drug restore the function and structure of beta cells in Type-2 diabetes. Biomed. Pharmacother. 84 (2016), 810–820, 10.1016/j.biopha.2016.09.068.
62. Stephen Irudayaraj, S., Christudas, S., Antony, S., Duraipandiyan, V., Naif Abdullah, A.D., Ignacimuthu, S., Protective effects of Ficus carica leaves on glucose and lipids levels, carbohydrate metabolism enzymes and beta-cells in type 2 diabetic rats. Pharm. Biol. 55:1 (2017), 1074–1081, 10.1080/13880209.2017.1279671.
63. Lian, J., Chen, J., Yuan, Y., Daud, M.S.M., Luo, L., Zhu, Y., Li, S., Bu, S., Cortex Mori Radicis extract attenuates myocardial damages in diabetic rats by regulating ERS. Biomed. Pharmacother. 90 (2017), 777–785, 10.1016/j.biopha.2017.03.097.
64. Hu, S.H., Jiang, T., Yang, S.S., Yang, Y., Pioglitazone ameliorates intracerebral insulin resistance and tau-protein hyperphosphorylation in rats with type 2 diabetes. Exp. Clin. Endocrinol. Diabetes 121:4 (2013), 220–224, 10.1055/s-0032-1333277.
65. Li, R.Y., Zhang, Q.H., Liu, Z., Qiao, J., Zhao, S.X., Shao, L., Xiao, H.S., Chen, J.L., Chen, M.D., Song, H.D., Effect of short-term and long-term fasting on transcriptional regulation of metabolic genes in rat tissues. Biochem. Biophys. Res. Commun. 344:2 (2006), 562–570, 10.1016/j.bbrc.2006.03.155.
66. Breyer, M.D., Bottinger, E., Brosius, F.C. 3rd, Coffman, T.M., Harris, R.C., Heilig, C.W., Sharma, K., Mouse models of diabetic nephropathy. J. Am. Soc. Nephrol. 16:1 (2005), 27–45, 10.1681/ASN.2004080648.
67. Wang, H.J., Jin, Y.X., Shen, W., Neng, J., Wu, T., Li, Y., Fu, Z.W., Low dose streptozotocin (STZ) combined with high energy intake can effectively induce type 2 diabetes through altering the related gene expression. Asia Pac. J. Clin. Nutr. 16 (2007), 412–417.
68. Xing, X.H., Zhang, Z.M., Hu, X.Z., Wu, R.Q., Xu, C., Antidiabetic effects of Artemisia sphaerocephala Krasch. gum, a novel food additive in China, on streptozotocin-induced type 2 diabetic rats. J. Ethnopharmacol. 125:3 (2009), 410–416, 10.1016/j.jep.2009.07.021.
69. Antony, P.J., Gandhi, G.R., Stalin, A., Balakrishna, K., Toppo, E., Sivasankaran, K., Ignacimuthu, S., Al-Dhabi, N.A., Myoinositol ameliorates high-fat diet and streptozotocin-induced diabetes in rats through promoting insulin receptor signaling. Biomed. Pharmacother. 88 (2017), 1098–1113, 10.1016/j.biopha.2017.01.170.
70. Jiao, Y., Wang, X., Jiang, X., Kong, F., Wang, S., Yan, C., Antidiabetic effects of Morus alba fruit polysaccharides on high-fat diet- and streptozotocin-induced type 2 diabetes in rats. J. Ethnopharmacol. 199 (2017), 119–127, 10.1016/j.jep.2017.02.003.
71. Sahin, K., Tuzcu, M., Orhan, C., Sahin, N., Kucuk, O., Ozercan, I.H., Juturu, V., Komorowski, J.R., Anti-diabetic activity of chromium picolinate and biotin in rats with type 2 diabetes induced by high-fat diet and streptozotocin. Br. J. Nutr. 110:2 (2013), 197–205, 10.1017/S0007114512004850.
72. Mahmoud, A.M., Abdel-Rahman, M.M., Bastawy, N.A., Eissa, H.M., Modulatory effect of berberine on adipose tissue PPARγ, adipocytokines and oxidative stress in high fat diet/streptozotocin-induced diabetic rats. J. Appl. Pharm. Sci., 7(4), 2017, 10.7324/JAPS.2017.70401.
73. Danda, R.S., Habiba, N.M., Rincon-Choles, H., Bhandari, B.K., Barnes, J.L., Abboud, H.E., Pergola, P.E., Kidney involvement in a nongenetic rat model of type 2 diabetes. Kidney Int. 68:6 (2005), 2562–2571, 10.1111/j.1523-1755.2005.00727.x.
74. Zhang, F., Ye, C., Li, G., Ding, W., Zhou, W., Zhu, H., Chen, G., Luo, T., Guang, M., Liu, Y., Zhang, D., Zheng, S., Yang, J., Gu, Y., Xie, X., Luo, M., The rat model of type 2 diabetic mellitus and its glycometabolism characters. Exp. Anim. 52:5 (2003), 401–407.
75. Zhao, H., Li, Z., Tian, G., Gao, K., Zhao, B., Wang, J., Luo, L., Pan, Q., Zhang, W., Wu, Z., Chen, J., Wang, W., Effects of traditional Chinese medicine on rats with Type II diabetes induced by high-fat diet and streptozotocin: a urine metabonomic study. Afr. Health Sci. 13:3 (2013), 673–681, 10.4314/ahs.v13i3.22.
76. Sun, W., Sang, Y., Zhang, B., Yu, X., Xu, Q., Xiu, Z., Dong, Y., Synergistic effects of acarbose and an Oroxylum indicum seed extract in streptozotocin and high-fat-diet induced prediabetic mice. Biomed. Pharmacother. 87 (2017), 160–170, 10.1016/j.biopha.2016.12.096.
77. Tohidi, M., Ghasemi, A., Hadaegh, F., Derakhshan, A., Chary, A., Azizi, F., Age- and sex-specific reference values for fasting serum insulin levels and insulin resistance/sensitivity indices in healthy Iranian adults: Tehran Lipid and Glucose Study. Clin. Biochem. 47:6 (2014), 432–438, 10.1016/j.clinbiochem.2014.02.007.
78. Ghasemi, A., Tohidi, M., Derakhshan, A., Hasheminia, M., Azizi, F., Hadaegh, F., Cut-off points of homeostasis model assessment of insulin resistance, beta-cell function, and fasting serum insulin to identify future type 2 diabetes: Tehran Lipid and Glucose Study. Acta Diabetol. 52:5 (2015), 905–915, 10.1007/s00592-015-0730-3.
79. Wilson, R.D., Islam, M.S., Fructose-fed streptozotocin-injected rat: an alternative model for type 2 diabetes. Pharmacol. Rep. 64:1 (2012), 129–139.
80. Khalifi, S., Rahimipour, A., Jeddi, S., Ghanbari, M., Kazerouni, F., Ghasemi, A., Dietary nitrate improves glucose tolerance and lipid profile in an animal model of hyperglycemia. Nitric Oxide 44 (2015), 24–30, 10.1016/j.niox.2014.11.011.
81. Bonner-Weir, S., Trent, D.F., Honey, R.N., Weir, G.C., Responses of neonatal rat islets to streptozotocin: limited B-cell regeneration and hyperglycemia. Diabetes 30:1 (1981), 64–69.
82. Rerup, C.C., Drugs producing diabetes through damage of the insulin secreting cells. Pharmacol. Rev. 22:4 (1970), 485–518.
83. Reuter, T.Y., Diet-induced models for obesity and type 2 diabetes. Drug Discov. Today: Dis. Models 4:1 (2007), 3–8, 10.1016/j.ddmod.2007.09.004.
84. Bevan, P., Insulin signalling. J. Cell Sci. 114:8 (2001), 1429–1430.
85. Mora, A., Komander, D., van Aalten, D.M.F., Alessi, D.R., PDK1, the master regulator of AGC kinase signal transduction. Semin. Cell Dev. Biol., 2004, 161–170.
86. Sakamoto, K., Holman, G.D., Emerging role for AS160/TBC1D4 and TBC1D1 in the regulation of GLUT4 traffic. Am. J. Physiol. Endocrinol. Metab. 295:1 (2008), E29–E37, 10.1152/ajpendo.90331.2008.
87. Harrington, L.S., Findlay, G.M., Lamb, R.F., Restraining PI3K: mTOR signalling goes back to the membrane. Trends Biochem. Sci. 30:1 (2005), 35–42, 10.1016/j.tibs.2004.11.003.
88. Kitamura, T., Kitamura, Y., Kuroda, S., Hino, Y., Ando, M., Kotani, K., Konishi, H., Matsuzaki, H., Kikkawa, U., Ogawa, W., Insulin-induced phosphorylation and activation of cyclic nucleotide phosphodiesterase 3B by the serine-threonine kinase Akt. Mol. Cell. Biol. 19:9 (1999), 6286–6296.
89. Grundleger, M.L., Thenen, S.W., Decreased insulin binding, glucose transport, and glucose metabolism in soleus muscle of rats fed a high fat diet. Diabetes 31:3 (1982), 232–237.
90. Youngren, J.F., Paik, J., Barnard, R.J., Impaired insulin-receptor autophosphorylation is an early defect in fat-fed, insulin-resistant rats. J. Appl. Physiol. (1985) 91:5 (2001), 2240–2247.
91. Zierath, J.R., Houseknecht, K.L., Gnudi, L., Kahn, B.B., High-fat feeding impairs insulin-stimulated GLUT4 recruitment via an early insulin-signaling defect. Diabetes 46:2 (1997), 215–223.
92. Kim, J.-Y., Hickner, R.C., Cortright, R.L., Dohm, G.L., Houmard, J.A., Lipid oxidation is reduced in obese human skeletal muscle. Am. J. Physiol. Endocrinol. Metab. 279:5 (2000), E1039–E1044.
93. Iossa, S., Lionetti, L., Mollica, M.P., Crescenzo, R., Botta, M., Barletta, A., Liverini, G., Effect of high-fat feeding on metabolic efficiency and mitochondrial oxidative capacity in adult rats. Br. J. Nutr. 90:5 (2003), 953–960.
94. Moraes, R.C., Blondet, A., Birkenkamp-Demtroeder, K., Tirard, J., Orntoft, T.F., Gertler, A., Durand, P., Naville, D., Begeot, M., Study of the alteration of gene expression in adipose tissue of diet-induced obese mice by microarray and reverse transcription-polymerase chain reaction analyses. Endocrinology 144:11 (2003), 4773–4782, 10.1210/en.2003-0456.
95. Yasuhara, R., Miyamoto, Y., Akaike, T., Akuta, T., Nakamura, M., Takami, M., Morimura, N., Yasu, K., Kamijo, R., Interleukin-1beta induces death in chondrocyte-like ATDC5 cells through mitochondrial dysfunction and energy depletion in a reactive nitrogen and oxygen species-dependent manner. Biochem. J. 389 (2005), 315–323, 10.1042/BJ20041996.
96. Pan, D.A., Storlien, L.H., Dietary lipid profile is a determinant of tissue phospholipid fatty acid composition and rate of weight gain in rats. J. Nutr. 123:3 (1993), 512–519.
97. Yaqoob, P., Sherrington, E.J., Jeffery, N.M., Sanderson, P., Harvey, D.J., Newsholme, E.A., Calder, P.C., Comparison of the effects of a range of dietary lipids upon serum and tissue lipid composition in the rat. Int. J. Biochem. Cell Biol. 27:3 (1995), 297–310.
98. Anai, M., Funaki, M., Ogihara, T., Kanda, A., Onishi, Y., Sakoda, H., Inukai, K., Nawano, M., Fukushima, Y., Yazaki, Y., Kikuchi, M., Oka, Y., Asano, T., Enhanced insulin-stimulated activation of phosphatidylinositol 3-kinase in the liver of high-fat-fed rats. Diabetes 48:1 (1999), 158–169.
99. Cai, D., Yuan, M., Frantz, D.F., Melendez, P.A., Hansen, L., Lee, J., Shoelson, S.E., Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. Nat. Med. 11:2 (2005), 183–190, 10.1038/nm1166.
100. Hansen, P.A., Han, D.H., Marshall, B.A., Nolte, L.A., Chen, M.M., Mueckler, M., Holloszy, J.O., A high fat diet impairs stimulation of glucose transport in muscle. Functional evaluation of potential mechanisms. J. Biol. Chem. 273:40 (1998), 26157–26163.
101. Liu, Z., Patil, I.Y., Jiang, T., Sancheti, H., Walsh, J.P., Stiles, B.L., Yin, F., Cadenas, E., High-fat diet induces hepatic insulin resistance and impairment of synaptic plasticity. PLOS ONE, 10(5), 2015, e0128274, 10.1371/journal.pone.0128274.
102. Rossmeisl, M., Rim, J.S., Koza, R.A., Kozak, L.P., Variation in type 2 diabetes-related traits in mouse strains susceptible to diet-induced obesity. Diabetes 52:8 (2003), 1958–1966.
103. Clegg, D.J., Benoit, S.C., Reed, J.A., Woods, S.C., Dunn-Meynell, A., Levin, B.E., Reduced anorexic effects of insulin in obesity-prone rats fed a moderate-fat diet. Am. J. Physiol. Regul. Integr. Comp. Physiol. 288:4 (2005), R981–R986, 10.1152/ajpregu.00675.2004.
104. Pecoraro, N., Ginsberg, A.B., Warne, J.P., Gomez, F., la Fleur, S.E., Dallman, M.F., Diverse basal and stress-related phenotypes of Sprague Dawley rats from three vendors. Physiol. Behav. 89:4 (2006), 598–610, 10.1016/j.physbeh.2006.07.019.
105. Peckham, S.C., Entenman, C., The influence of a hypercaloric diet on gross body and adipose tissue composition in the rat. Res. Dev. Tech. Rep., 1962, 23.
106. Peyron-Caso, E., Quignard-Boulangé, A., Laromiguière, M., Feing-Kwong-Chan, S., Véronèse, A., Ardouin, B., Slama, G., Rizkalla, S.W., Dietary fish oil increases lipid mobilization but does not decrease lipid storage-related enzyme activities in adipose tissue of insulin-resistant, sucrose-fed rats. J. Nutr. 133:7 (2003), 2239–2243.
107. Jump, D.B., Dietary polyunsaturated fatty acids and regulation of gene transcription. Curr. Opin. Lipidol. 13:2 (2002), 155–164.
108. Ghibaudi, L., Cook, J., Farley, C., van Heek, M., Hwa, J.J., Fat intake affects adiposity, comorbidity factors, and energy metabolism of Sprague-Dawley rats. Obes. Res. 10:9 (2002), 956–963, 10.1038/oby.2002.130.
109. Zhang, T., Pan, B.S., Zhao, B., Zhang, L.M., Huang, Y.L., Sun, F.Y., Exacerbation of poststroke dementia by type 2 diabetes is associated with synergistic increases of β-secretase activation and β-amyloid generation in rat brains. Neuroscience 161:4 (2009), 1045–1056, 10.1016/j.neuroscience.2009.04.032.
110. Ren, Z., Li, W., Zhao, Q., Ma, L., Zhu, J., The impact of 1,25-dihydroxy vitamin D3 on the expressions of vascular endothelial growth factor and transforming growth factor-beta(1) in the retinas of rats with diabetes. Diabetes Res. Clin. Pract. 98:3 (2012), 474–480, 10.1016/j.diabres.2012.09.028.
111. Islam, M.S., Choi, H., Loots, D.T., Effects of dietary onion (Allium cepa L.) in a high-fat diet streptozotocin-induced diabetes rodent model. Ann. Nutr. Metab. 53:1 (2008), 6–12.
112. Ansarullah, B.P., Bharucha, Vaibhav, Ramachandran, A.V., Improved glucoregulation, insulin resistance and leptin levels by a polyherbal drug in high fat diet and low dose streptozotocin type 2 diabetes model. Diabetol. Croat. 41:1 (2012), 3–15.
113. Kaiser, N., Sasson, S., Feener, E.P., Boukobza-Vardi, N., Higashi, S., Moller, D.E., Davidheiser, S., Przybylski, R.J., King, G.L., Differential regulation of glucose transport and transporters by glucose in vascular endothelial and smooth muscle cells. Diabetes 42:1 (1993), 80–89.
114. Brownlee, M., The pathobiology of diabetic complications – a unifying mechanism. Diabetes 54:6 (2005), 1615–1625, 10.2337/diabetes.54.6.1615.
115. Chen, J., Meng, Y., Zhou, J., Zhuo, M., Ling, F., Zhang, Y., Du, H., Wang, X., Identifying candidate genes for type 2 diabetes mellitus and obesity through gene expression profiling in multiple tissues or cells. J. Diabetes Res., 2013, 2013, 9, 10.1155/2013/970435.
116. Carvalho, E., Jansson, P.A., Axelsen, M., Eriksson, J.W., Huang, X., Groop, L., Rondinone, C., Sjostrom, L., Smith, U., Low cellular IRS 1 gene and protein expression predict insulin resistance and NIDDM. FASEB J. 13:15 (1999), 2173–2178.
117. Kipmen-Korgun, D., Bilmen-Sarikcioglu, S., Altunbas, H., Demir, R., Korgun, E.T., Type-2 diabetes down-regulates glucose transporter proteins and genes of the human blood leukocytes. Scand. J. Clin. Lab. Invest. 69:3 (2009), 350–358, 10.1080/00365510802632163.
118. Krabbe, K.S., Nielsen, A.R., Krogh-Madsen, R., Plomgaard, P., Rasmussen, P., Erikstrup, C., Fischer, C.P., Lindegaard, B., Petersen, A.M., Taudorf, S., Secher, N.H., Pilegaard, H., Bruunsgaard, H., Pedersen, B.K., Brain-derived neurotrophic factor (BDNF) and type 2 diabetes. Diabetologia 50:2 (2007), 431–438, 10.1007/s00125-006-0537-4.
119. Yang, Q., Graham, T.E., Mody, N., Preitner, F., Peroni, O.D., Zabolotny, J.M., Kotani, K., Quadro, L., Kahn, B.B., Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature 436:7049 (2005), 356–362, 10.1038/nature03711.
120. Calabrese, V., Cornelius, C., Leso, V., Trovato-Salinaro, A., Ventimiglia, B., Cavallaro, M., Scuto, M., Rizza, S., Zanoli, L., Neri, S., Castellino, P., Oxidative stress, glutathione status, sirtuin and cellular stress response in type 2 diabetes. Biochim. Biophys. Acta 1822:5 (2012), 729–736, 10.1016/j.bbadis.2011.12.003.